, Tracking Stock Market Picks
Enter Symbol:
United Therapeutics Corporation (UTHR) [hlAlert]

down 75.11 %

United Therapeutics Corporation (UTHR) rated Sell with price target $45 by Auriga

Posted on: Thursday,  Aug 25, 2011  8:25 AM ET by Auriga

Auriga rated Sell United Therapeutics Corporation (NASDAQ: UTHR) on 08/25/2011, when the stock price was $39.88. Since
then, United Therapeutics Corporation has gained 301.81% as of 01/27/2016's recent price of $160.24.
If you would have followed this Auriga's recommendation on UTHR, you would have lost 75.11% of your investment in 1616 days.

UTD THERAPEUTIC is a biotechnology company focused on combating cardiovascular, inflammatory, and infectious diseases with unique therapeutic products. These products include pharmaceuticals, arginine products and telemedicine services.

Auriga operates full-service institutional equity and fixed income trading desks with state-of-the-art communications technology and trading systems. Through our U.S. corprate parent, Auriga Holdings, LLC we offer a variety of services including whole loan trading and asset management. Through our Spanish parent company, Auriga Securities Sociedad de Valores, S.A., we offer the ability to trade European equity and fixed income products. We connect electronically to buy-side firms; route orders to multiple points of execution and subsequently route to our clearing firm, Pershing, for settlement.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/25/2011 8:25 AM Sell
39.88 45.00
as of 12/30/2011
1 Week down  -1.48 %
1 Month down  -15.49 %
3 Months down  -26.03 %
1 YTD down  -18.48 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy